MammaPrint, the lead product in the privately held company's pipeline, received clearance from the US Food and Drug Administration in as a prognostic assay that analyzes the expression of 70 genes and helps doctors discern whether their patients' breast cancer will recur within five to 10 years. MammaPrint, which operates on an Agilent microarray-based platform, initially analyzed fresh tissue samples. According to Macdonald, the company was starting to see increasing adoption rates for MammaPrint and other diagnostics in , but introducing FFPE analysis this year has further bolstered sales. Then, "in , we've doubled our sales again. If you look at Agendia on a consolidated basis, we've more than doubled our volume from first quarter last year to first quarter this year.
Stephanie Akbari, M.D., F.A.C.S. - Virginia Cancer Specialists
Stephanie Akbari January 17, Liz Dowling: Welcome, Dr. Thank you. Liz Dowling: How do you begin to help them cope with their diagnosis?
Dr. Stephanie Akbari, MD
Shulman ,4 and John G. Thomas E. This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Citations to this Article [57 citations] The following is the list of published articles that have cited the current article. Meteb Al-Foheidi, Mubarak M.
Medicinae Doctor, meaning "Teacher of Medicine", is a terminal degree for physicians and surgeons. In countries that follow the tradition of the United States, it is a first professional graduate degree awarded upon graduation from medical school. Education and Training Dr. The Physician Quality Reporting System PQRS is a Medicare program encouraging health care professionals and group practices to report information on their quality of care. Quality measures can show how well a health care professional provides care to people with Medicare.